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ABSTRACT For over 20 years, bacterial multidrug resistance (MDR) efflux pumps have been studied because of their impact on
resistance to antimicrobials. However, critical questions remain, including why produce efflux pumps under non-antimicrobial
treatment conditions, and why have multiple pumps if their only purpose is antimicrobial efflux? Salmonella spp. possess five
efflux pump families, including the resistance-nodulation-division (RND) efflux pumps. Notably, the RND efflux pump AcrD
has a unique substrate profile, distinct from other Salmonella efflux pumps. Here we show that inactivation of acrD results in a
profoundly altered transcriptome andmodulation of pathways integral to Salmonella biology. The most significant transcrip-
tome changes were central metabolism related, with additional changes observed in pathogenicity, environmental sensing, and
stress response pathway expression. The extent of tricarboxylic acid cycle and fumarate metabolism expression changes led us to
hypothesize that acrD inactivationmay result in motility defects due to perturbation of metabolite concentrations, such as fu-
marate, for which a role in motility has been established. Despite minimal detectable changes in flagellar gene expression, we
found that an acrDmutant Salmonella enterica serovar Typhimurium isolate was significantly impaired for swarming motility,
which was restored by addition of fumarate. The acrDmutant outcompeted the wild type in fitness experiments. The results of
these diverse experiments provide strong evidence that the AcrD efflux pump is not simply a redundant system providing re-
sponse resilience, but also has distinct physiological functions. Together, these data indicate that the AcrD efflux pump has a
significant and previously underappreciated impact on bacterial biology, despite only minor perturbations of antibiotic resis-
tance profiles.
IMPORTANCE Efflux pumps in Gram-negative bacteria are studied because of their important contributions to antimicrobial re-
sistance. However, the role of these pumps in bacterial biology has remained surprisingly elusive. Here, we provide evidence that
loss of the AcrD efflux pump significantly impacts the physiology of Salmonella enterica serovar Typhimurium. Inactivation of
acrD led to changes in the expression of 403 genes involved in fundamental processes, including basic metabolism, virulence,
and stress responses. Pathways such as these allow Salmonella to grow, survive in the environment, and cause disease. Indeed,
our data show that the acrDmutant is more fit than wild-type Salmonella under standard lab conditions. We hypothesized that
inactivation of acrDwould alter levels of bacterial metabolites, impacting traits such as swarmingmotility. We demonstrated
this by exogenous addition of the metabolite fumarate, which partially restored the acrDmutant’s swarming defect. This work
extends our understanding of the role of bacterial efflux pumps.
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Resistance-nodulation-division (RND) efflux pumps in Gram-negative bacteria confer intrinsicmultidrug resistance (MDR)
by exporting a broad range of antimicrobial compounds out of the
bacterial cell. Traditionally, Enterobacteriaceae such as Escherichia
coli and Salmonella have five families of efflux pumps, the ABC
and MFS superfamilies and the SMR, MATE, and RND families
(1). Recently, the PACE family of efflux pumps was discovered in
Acinetobacter species and is present in a range of Proteobacteria (2,
3). Salmonella enterica serovar Typhimurium (here, Salmonella
Typhimurium) is used extensively as a model pathogen for many
reasons, including easy genetic manipulation, good infection
models, and relevance to other pathogens (4, 5). Salmonella Ty-
phimurium has five RND MDR efflux systems: AcrAB, AcrAD,
AcrEF, MdtABC, and MdsABC (5, 6). AcrB, and its homologues
in other Gram-negative pathogens (e.g., MexB in Pseudomonas
aeruginosa and CmeB in Campylobacter jejuni) is considered the
most important RND system to human health because it trans-
ports a wide range of structurally varied antimicrobials and is
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more abundant within the cell than other efflux pumps (for a
review, see reference 7). Furthermore, inactivation of acrB in Sal-
monella (and its homologues in other bacteria) confers multidrug
hypersusceptibility, while single deletions of the other RND efflux
pump genes have little or no effect on susceptibility to most anti-
microbial agents (5, 8, 9). Interestingly, AcrD has 70% nucleotide
and 79% amino acid similarity with AcrB (9), yet it possesses a
distinct substrate profile that includes aminoglycoside antibiotics
(10, 11). AcrB and AcrD also differ in the structures of their prox-
imal binding pockets, whichmay underpin the differences in their
substrate profiles (12). We have previously shown that the AcrD
efflux pump impacts biofilm formation, as evidenced by an acrD
mutant that showed significantly reduced biofilm formation and
reduced expression of key biofilmproteins encoded by csgBD (13).
Little is known about the natural and potentially homeostatic
functions of efflux pumps in pathogen biology. Efflux pumps are
evolutionarily ancient proteins which long predate the use of an-
tibiotics (14). In Salmonella, the AcrAB-TolC efflux pump is in-
volved in protection from and efflux of bile and toxic bile salts
(15–21). In E. coli, a physiological substrate is the siderophore
enterobactin, which is effluxed byAcrAB-TolC, AcrAD-TolC, and
MdtABCpumps (22–24). To further understand the natural func-
tion of AcrB in Salmonella, we previously determined the tran-
scriptome of a Salmonella acrB mutant; the effect was profound
and correlated with an altered basic biology of the organism (25).
Furthermore, we previously showed that inactivation of individ-
ual or multiple acr efflux pump genes results in increased expres-
sion of the remaining efflux pump genes, suggesting a sensing
mechanism to detect and regulate relative expression levels of the
different pumps (9). When acrB was deleted, acrD expression in-
creased (9). While the physiological role of AcrB is becoming
clearer, much less is known about the functions of AcrD. There-
fore, we sought to understand how loss of AcrD impacted the
biology of the organism and whether loss of this pump led to
changes to Salmonella physiology.
In the current study, we determined the transcriptome of a
Salmonella mutant, constructed and tested previously (8, 9), in
which acrD had been genetically inactivated. Here, we demon-
strate that multiple genes, including those involved in metabo-
lism, stress responses, and virulence, were altered by acrD inacti-
vation. Using these transcriptomic data as a guide, we examined
phenotypic differences between the parental strain and the acrD
mutant. Specifically, we explored the ability of an acrD Salmonella
mutant to swimand swarm, growon various carbon sources, grow
under anaerobic conditions, and invade polarized epithelial cells,
andwe tested the fitness of the acrDmutant relative to the parental
strain. Our data suggest that AcrD has a different role in the biol-
ogy of the organism than previously assumed.
RESULTS
Inactivation of acrD leads to distinct transcriptional changes.
The transcriptome of the acrD mutant revealed significantly al-
tered expression of 403 genes compared to the parental SL1344
strain (for a list of genes with significantly altered expression, see
Table S1 in the supplemental material; full microarray data are
available at http://www.ebi.ac.uk/arrayexpress/experiments/E-
MEXP-2975/samples/). Specifically, in the acrD mutant expres-
sion of genes encoding proteins involved in anaerobic growth,
ATP synthesis, amino acid metabolism, sugar transport, glycoly-
sis/gluconeogenesis, ribosomal subunit biosynthesis, RNA poly-
merase, and oxidative phosphorylation were generally increased
(Fig. 1). Expression of genes associated with pathogenicity, sigma
factors, stress response, the tricarboxylic acid (TCA) cycle, and
purinemetabolismwere generally decreased (Fig. 1). Surprisingly,
very few of the transcriptomic changes could be directly linked to
drug export.
It seemed unlikely that the changes observed at the transcrip-
tomic level were simply due to the lack of a large membrane pro-
tein. If this were the case, wewould expect the deletion of acrD and
acrB to result in similar changes and also changes in membrane
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FIG 1 The gene expression changes of SL1344 acrD::aph compared to wild-type SL1344. Genes with altered expression in the acrD mutant were categorized
according to function. The horizontal axis indicates the number of genes in each category, with negative values indicating genes that were downregulated and
positive values indicating genes that were upregulated.
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stress response genes, e.g., cpxAR and baeSR (26–28). Both CpxR
andBaeR are known to induce expression of efflux pumps, includ-
ing AcrD (26, 29, 30). In E. coli, inactivation of tolC activates the
Cpx and Bae pathways (28). However, there was no significant
change in expression of either the cpx or bae gene in the acrD
mutant.
Carbonmetabolism is largelyunalteredby loss ofacrD.Since
many of the observed transcriptional changes involved genes that
encode products involved in carbon utilization, the Biolog pheno-
typic microarray system (Biolog, Inc., USA) was used to measure
the respiration of the wild type and acrD mutant on various car-
bon sources (PM1 and PM2A). The respiration levels on different
carbon sources for the acrDmutant and the wild-type strain were
very similar, with only one major difference observed. The acrD
mutant had significantly higher respiration levels on saccharate
relative to that of wild-type Salmonella (P 0.0037).
In order to validate the results from the phenotypic microar-
rays and to determine if the change in respiration was also associ-
ated with a change in growth, selected carbon sources were tested.
Growth in M9 minimal medium supplemented with glucose,
fructose, succinate, aspartate, pyruvate, or saccharate was exam-
ined (see Fig. S1 in the supplemental material). As a control,
growth of the acrD mutant and wild-type Salmonella in LB broth
was measured, and no differences were found in generation time
or the final optical density (OD) at 19 h (Fig. S2). The generation
time of the acrD mutant was not significantly different when
grown with glucose, fructose, succinate, aspartate, pyruvate, or
saccharate as a carbon source (Fig. S3a). Likewise, measurement
of the final OD of the culture indicated that the acrD mutant and
wild-type strain grew to similar final densities on the carbon
sources tested (Fig. S3b).
Inactivation of acrD leads to increased expression of nitrate
reductase and nitrite reductase genes. In the acrD mutant, the
expression of six genes (napACF and nirBCD) involved in anaer-
obic growth was increased between 3.06- and 22.83-fold (Ta-
ble S1). However, under anaerobic conditions, there was no sig-
nificant difference in the generation time (Fig. S4a) or the finalOD
(Fig. S4b) of the acrD mutant culture compared to the wild-type
parental strain. Additionally, there was no difference in growth in
1 mM sodium nitrate, nor was there a difference in survival in
10 mM acidified sodium nitrite (data not shown).
Inactivation of acrD results in reduced virulence gene ex-
pression. Inactivation of acrD led to decreased expression of 13
genes known to be involved in Salmonella virulence. The expres-
sion levels of genes from Salmonella pathogenicity islands 1
(SPI-1), -2, -3, -10, and -18 were significantly decreased (0.05- to
0.5-fold, which corresponds to a 20- to 2-fold reduction) (see
Table S1). This included reduced expression of genes encoding
secreted proteins (cigR and sseBCDE) and virulence protein chap-
erones (sicP and sscAB), while expression of a gene encoding a
needle apparatus sorting platform component (orgA) was in-
creased.
Genes from SPI-1 have been shown to be expressed by only a
portion of the total population (31–33), so techniques such as
microarrays and reverse transcription-PCR (RT-PCR), which
measure gene expression across a whole population, only provide
partial information about gene expression of individual bacteria
in a population. The expression of the SPI-1 gene prgH, which
encodes the essential basal component of the needle complex of
the SPI-1 type III secretion system, has been used previously to
measure expression of SPI-1 in single cells (31, 34). Therefore,
strains containing the promoter of prgH fused to the green fluo-
rescent protein gene gfp were used to compare the percentage of
cells in the population that expressed SPI-1 in the acrD mutant
versus in the wild type, as described previously (31, 34). This
showed that when acrD was inactivated, fewer cells expressed
SPI-1 than did wild-type Salmonella cells (Fig. 2). These findings
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FIG 2 SPI-1 expression of the acrD::aph strain. Strains containing the pro-
moter of prgH (SPI-1) fused to gfp were analyzed by flow cytometry and the
number of fluorescent and nonfluorescent cells were enumerated. (a) Mean
results standard deviations. *, P 0.05. (b) A representative example of the
flow cytometry results for SL1344 and SL1344 acrD::aph cells.
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correlate with the decreased detection of SPI-1 transcripts in the
acrD mutant microarray analysis (Table S1).
Intriguingly, this reduction in the proportion of bacteria ex-
pressing SPI-1 did not correlate with decreased invasion of the
acrD mutant into Caco-2 polarized epithelial cells. There was no
difference in the virulence of the acrD mutant compared to the
parental SL1344 strain; as there was no difference between wild-
type SL1344 and the acrD::aph strain in association (2 h), invasion
(4 h), and persistence (8 and 24 h) in Caco-2 polarized epithelial
cells (P 0.745,P 0.846,P 0.942, andP 0.685, respectively)
(Fig. S5).
Inactivation of acrD reduces motility. Compared to SL1344,
the acrD mutant was impaired for swimming. SL1344 swam to
cover an average area of 471.5 mm2, while the acrD mutant cov-
ered 266.7 mm2 (P 0.0018) (Fig. 3a). Likewise, the acrDmutant
was impaired for swarming compared with SL1344, which cov-
ered an average area of 6,090 mm2 while the acrDmutant covered
510 mm2 (P  0.001) (Fig. 3b). The swimming assay produces
results that are inherently variable, and so we minimized this im-
pact by performing 13 replicates.
Since there were no changes in expression of commonmotility
genes found in the transcriptome (e.g., flagellar genes), yet we
observed a drastic impact on motility, we explored the effect of
metabolites on motility. This was because expression levels of
many metabolism-associated genes were altered in the transcrip-
tome. Fumarate has been shown to impact the switching of the
direction of flagellum rotation (35–37). Furthermore, the tran-
scriptomic data showed increased expression of frdABCD and
aspA, as well as decreased expression of sdhCDA and fumC (see
Table S1), the gene products of which impact fumarate levels. To
determine if fumarate could restore the motility defect seen in the
acrD mutant, exogenous fumarate was added to the culture me-
dium.At concentrations of 0.1, 0.25, 0.5, 1, 2, and 4mM, fumarate
inhibited swimmingmotility of wild-type SL1344 (P 0.004, P
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FIG 3 Impact of fumarate on motility of acrD::aph mutant cells compared to SL1344 cells. Areas covered by SL1344 and SL1344 acrD::aph mutant cells for
swimming (a) and swarming (b) motility in LB alone and in the presence of increasing concentrations of fumarate are summarized. Data presented are from 13
replicates for LB alone and 4 replicates for fumarate, with mean values indicated. *, P 0.05; **, P 0.001.
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0.001, P 0.001, P 0.001, P 0.001, P 0.0016, respectively),
while concentrations of 0.01 and lower did not impact swimming
(Fig. 3a). For the acrD mutant, concentrations of 0.25, 0.5, 1, 2,
and 4mM fumarate inhibited swimmingmotility (P 0.015, P
0.041, P  0.016, P  0.020, P  0.018, respectively) (Fig. 3a).
Fumarate concentrations between 0.1 and 0.5 mM increased the
swarming ability of the acrD mutant (P  0.05 for 0.1, 0.25, and
0.5 mM fumarate) (Fig. 3b) compared with LB alone. Our data
indicate that the ability to swarm is either on or off. In LB alone, 9
replicates showed that the wild type swarmed very well and only
one replicate showed moderate swarming; for the acrD mutant, 8
replicates did not swarm at all and 2 replicates swarmed moder-
ately (Fig. 3b). At concentrations of 0.1, 0.25, and 0.5 mM fuma-
rate, the proportion of acrD mutants which did swarm increased
(P 0.05) (Fig. 3b). At 4mM fumarate, swarming of the wild type
was inhibited (P 0.001) (Fig. 3b). One limitation of this exper-
iment was that the swarming wild-type bacteria reached the edge
of the plate, and we were unable to determine if fumarate in-
creased swarming of SL1344 by the same magnitude as in the
mutant.
InactivationofacrD impacts bacterial fitness. Sincenodiffer-
ences were seen in growth when evaluated under a variety of con-
ditions, yet expression levels of 403 genes were altered, we hypoth-
esized that these numerous gene expression changes would alter
the fitness of the acrDmutant in a competitive environment. Bac-
terial fitness can be determined in a number of different ways;
initially we tested fitness under standard laboratory conditions in
vitro (LB broth, 37°C with aeration, inoculation with a 50:50 ratio
of wild-type Salmonella to acrDmutant). Under these conditions,
the acrD mutant outcompeted the wild type as early as 4 h posti-
noculation (Fig. 4a). After 2 h of growth, the acrD mutant com-
posed 57% of the population, and by 4 h 92% of the bacteria were
acrDmutants (P 0.001). This high proportion rose to 97%at 6 h
(P  0.001) and then varied between 96% and 99% (P  0.001)
for the remainder of the 72 h, which included passaging into fresh
medium at 12, 24, and 48 h.
Tomeasure fitness under in vivo conditions, competitive infec-
tion experiments were carried out. Polarized Caco-2 epithelial
cells were infectedwith a 50:50 ratio of wild-type Salmonella to the
acrD mutant. At 2, 4, 8, and 24 h postinfection, the proportion of
the acrD mutant to the wild-type SL1344 was not significantly
altered (Fig. 4b). This indicated there was no fitness differential
associated with the loss of acrD during the infection of polarized
Caco-2 epithelial cells (Fig. 4b).
DISCUSSION
Our data suggest that the AcrD efflux pump has a unique biolog-
ical role. This was demonstrated by the significant changes ob-
served in the transcriptome. Comparison of the transcriptomes of
the acrD mutant (presented in this work; further information is
available at http://www.ebi.ac.uk/arrayexpress/experiments/E-
MEXP-2975/samples/)with the previously published acrBmutant
transcriptome (25) showed that the effect was very distinct, which
supports the hypothesis that AcrD is not a “backup” efflux pump
but has its own physiological purpose in the cell. This comparison
identified 232 significant gene expression changes specific to the
inactivation of acrD and thatwere not affected by the disruption of
acrB. Compared to the acrBmutant transcriptome, 169 geneswere
differentially expressed by both acrB and acrD mutants. Of these,
expression of 91 genes was altered in the same way (e.g., increased
in both mutants), and 78 genes were expressed in an opposite
manner (e.g., increased in one but decreased in the other). There is
experimental evidence that AcrB and AcrD efflux pumps have
distinctive substrate profiles with respect to aminoglycoside anti-
biotics (10–12). Our data showed that deletion of either acrB or
acrD has different impacts on the bacterial transcriptome, which
supports the suggestion that these pumps have distinct roles. We
speculate that accumulation of certain metabolic intermediates in
the bacterial cell may trigger feedback mechanisms which alter
gene expression and metabolism in different ways (23, 38).
Some of the genes identified in the microarray were drastically
altered in the acrDmutant; for example, adh expression increased
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FIG 4 Impact of acrD inactivation on bacterial fitness. (a) Fitness under standard laboratory conditions in vitro. LB broth was inoculated with a 50:50 mixture
of wild-type and acrD mutant cells and grown at 37°C with aeration. Samples were taken at the indicated time points, and fresh cultures were inoculated every
24 h. Data presented are the means of three independent experiments with three biological replicates each, standard deviations. (b) Competitive infection of
polarized Caco-2 epithelial cells. After infection with a 50:50 mixture of wild-type and acrDmutant cells, association was determined at 2 h postinfection prior,
to gentamicin treatment. A gentamicin protection assay was used to calculate invasion and persistence at later time points. Replica plating was used to determine
the proportion of wild-type versus acrD::aph bacteria. Data presented are the means of three independent experiments performed, with 4 replicates each, 
standard deviations. *, P 0.05; **, P 0.001.
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70-fold and fruB increased 45-fold.On the other hand, some genes
had10-fold changes but these changes were still statistically sig-
nificant. These data are included in Table S1 in the supplemental
material for several reasons. First, depending on gene function,
small changes in expression can translate into significant changes
in the biology of the organism (39, 40). Second, multiple small
changes which occur in the same or related pathways can have
strong impacts on phenotypes (41, 42). In the data presented here,
the expression changes in genes involved in fumarate metabolism
(frdABCD and sdhCDA) were below 10-fold, yet fumarate had a
direct and significant impact on the acrD mutant’s motility
(Fig. 3). Third, these data, including the large and small changes,
will likely prove useful for the scientific community.
Nearly 100 genes associated with metabolism were altered by
the inactivation of acrD. Table S1 lists genes with significantly
altered expression; selected genes and operons are discussed be-
low. Expression of the pyruvate formate lyase I gene, pflB, in-
creased. PflB is involved in glucose metabolism, converting pyru-
vate to formate and acetate, and is preferentially used under
anaerobic conditions (43, 44). Abernathy et al. (44) found that
deletion of pflB led to increased intracellular replication in intes-
tinal epithelial cells as a result of increased SPI-1 expression. In our
study, the acrDmutant had increased pflB expression and reduced
SPI-1 expression, indicating another connection between efflux
pump gene expression, metabolism, and virulence. The fructose
operon (fruBKA), under the control of FruR (45), was upregulated
in the acrD mutant. However, there was no difference between
growth of the acrD mutant and wild type when fructose was used
as a carbon source. Another metabolism gene, ilvC, had higher
expression in the acrD mutant. IlvC is a component of the path-
way Salmonella uses to synthesize isoleucine and valine, and it is
encoded by ilvGEDAYC (46). ilvGEDA is an operon, but tran-
scription of ilvC is separate and dependent on IlvY (46). We were
surprised that the Biolog phenotypic microarray data did not in-
dicate significantly altered respiration of the acrD strain on carbon
sources other than saccharate. We hypothesize that the effect of
the transcriptional changes may be compensatory changes within
the mutant to ameliorate the effect of loss of AcrD.
Six genes, napACF and nirBCD, associated with nitrate and
nitrite reduction were upregulated when acrD was inactivated.
This contrasts with the reduction in expression of these same
genes in the acrB mutant (25). Salmonella has two nitrate reduc-
tases, one located in the cytoplasm and the other in the periplasm
(NapACF) (47). NirBD is an NADH-dependent nitrite reductase
located in the cytoplasm, while NirC is a nitrite/proton antiporter
in the bacterial membrane, that allows transport of nitrite into the
cytoplasm for detoxification (48, 49), and contributes to Salmo-
nella virulence in both mice and macrophages (50). However,
there was no difference in the ability of the acrD mutant to grow
anaerobically compared to wild-type Salmonella, nor was there a
significant difference in the ability of the mutant to grow in the
presence of sodium nitrate or survive in acidified nitrite. It seems
plausible that deletion of these genes, as in studies performed by
other groups, has a greater effect on phenotype than the level of
the increased expression (3.5- to 23-fold) seen in our acrD mu-
tant.
Among the differences in the transcriptomes, the expression
levels of genes involved in virulence were reduced in the acrD
mutant. Salmonella has several pathogenicity islands, including
SPI-1 and SPI-2, which contribute to invasion of nonphagocytic
cells aswell as survival and replicationwithin host cells (4, 51). The
SPI-1-associated genes, which were downregulated in the acrD
mutant, were different from the SPI-1 genes downregulated in the
acrBmutant (25). Our transcriptomic data indicate that inactiva-
tion of acrD led to reduced expression of SPI-1- and SPI-2-
associated chaperones, translocon components, and effectors. De-
spite the reduced expression of some SPI-1-associated genes and
the reduced proportion of bacteria expressing the SPI-1 appara-
tus, neither association, invasion, nor persistence in Caco-2
treated cells was impacted by the loss of acrD. A previous study
also showed no impact of acrD inactivation on adhesion or inva-
sion of INT-407 epithelial cells or on colonization and persistence
of 1-day-old and 2-week-old chicks between the acrDmutant and
wild-type strain SL1344 (52). In line with these findings, Nishino
et al. (2006) showed inactivation of acrD had minimal impact on
BALB/c mouse survival (5). In contradiction to the findings of
Buckley et al. (52) and Nishino et al. in 2006 (5), another study
found that the acrD strain was attenuated in an INT-407model of
infection (9). However the polarized Caco-2 epithelial cells used
in our study are more physiologically relevant. Furthermore, our
competitive infection data confirm that the acrDmutant is as fit as
wild-type Salmonella during infection. Salmonella invasion of po-
larized epithelial cells occurs in a highly cooperative manner with
multiple bacteria engulfed by Salmonella induced membrane ruf-
fles (53). We hypothesize that this cooperative entry accounts for
this apparent contradiction, as cells that express SPI-1 induce
ruffles, which engulf both SPI-1 expressing and non- SPI-1-
expressing bacteria.
The acrDmutant was able to outcompete the wild-type Salmo-
nella in vitro in the fitness experiment in LB culture medium. We
postulate that the metabolic shifts highlighted by the transcrip-
tomic data provide an advantage to the acrD mutant in the LB
fitness experiment. The cumulative effect of changes to metabolic
gene expression does not impair the ability of the mutant to out-
compete the parental strain.
Salmonella species are highly motile, and are capable of swim-
ming and swarming in a flagella dependent manner (54, 55).
Swimming is associated with counterclockwise rotation of the fla-
gella, and is often interspersed with tumbles, brought about by
switching direction of flagellar rotation (56). This ability to switch
rotation direction is also important for swarming motility, and is
controlled by the chemotaxis response regulator CheY (56).
Swarming Salmonella move within a wet “slime” layer composed
of polysaccharides, surfactants, and peptides (57, 58). In a gene
expression study conducted by Wang et al. 2004 (57), the flagella
operons were not upregulated during swarming. Swarming Sal-
monella also have distinct changes in basic metabolism, with glu-
cose a key energy source for the process (59). We made similar
observations in this study; expression of multiple metabolic but
not flagella specific genes was altered in the acrD mutant, yet sig-
nificant changes to swarming were detected.
Recent studies have focused on finding novel genes and/or
pathways which mediate swarming (60-62). A screen of a mutant
library containing 1023 mutants in S. typhimurium 14028s found
21 mutants with impaired swimming and swarming, forty nine
with impaired swimming, but normal swarming, and also 49 with
impaired swarming but normal swimming, and 39 hyper-motile
mutants (61). Further exploration of these novel motility genes
identified by Bogomolnaya et al. 2014 is needed. Future work un-
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coveringmore pathways and proteins directly involved in swarm-
ing may shed further light on our data.
Despite the drastic reduction in swarming motility of the acrD
mutant, we did not see significant changes in the expression of
genes known to impact motility and swarming, including cheY.
We observed significant changes in expression of genes associated
with the production of fumarate. The key enzymes in the inter-
conversion of succinate and fumarate are FrdABCD and Sdh-
CDAB (63). Under aerobic conditions, sdh is upregulated and
these proteins catalyze the oxidation of succinate at higher fre-
quency (64). In the acrD mutant, the sdhCDA genes were down-
regulated. Under anaerobic conditions, frd genes are upregulated
and fumarate can act as a terminal electron acceptor; however it is
a low energy yielding acceptor (63-66). In the acrD mutant the
frdABCD operon was upregulated, yet no difference in anaerobic
growth was seen. Together with the upregulation of aspA and
downregulation of fumC we hypothesized that the acrD mutant
has altered intracellular levels of fumarate.
Fumarate is associated with flagella rotation switching in a
model which uses cytoplasm free envelopes of both Salmonella
and E. coli where flagella are present, but do not normally change
directions (35). However, the addition of 1mM fumarate restores
the switching of flagella, even in the absence of CheY (35, 37).
With the addition of fumarate the flagella rotated in the clock-wise
direction more often; fumarate was shown to target the switch
motor complex (37). In line with these findings, when we added
fumarate (0.001 to 4 mM) to the swarming assay medium, there
was a clear increase in swarming of the acrDmutant at concentra-
tions of 0.1 to 0.5 mM. The intracellular concentration of fumar-
ate in S. typhimurium has previously been shown to be 0.23 M
( 0.12) (67), thus the exogenous levels of fumarate needed to
impact swarming (0.1 to 1 mM) are higher than those found
within the cell. Furthermore, there was an “all-or-nothing”
swarming phenotype, and the addition of fumarate increased the
proportion of the mutant bacteria that swarmed. Taken together,
we hypothesize that inactivation of the AcrD efflux pump leads to
altered levels of fumarate, which directly impacts swarming mo-
tility.
A recent elegant study examined the localization of AcrB, AcrD
and TolCwithin themembrane (68). In this study they found that
AcrB and AcrD formed stabilized foci when bound to TolC and
that as levels of AcrD increased, AcrB was displaced from TolC, a
phenomenon the authors call transporter exchange (68). This ex-
change did not occur when AcrB substrates were present (68).
Extrapolating this hypothesis provides a potential explanation of
our data; when acrD is deleted there are fewer competitors for
AcrB to bindwith TolC and therefore, the AcrAB-TolC complex is
stabilized, even in the absence of AcrB substrates. We postulate
this could affect the metabolite concentrations within the cell.
In summary, our study demonstrates important and signifi-
cant differences in bacterial gene expression occur as a result of
inactivation of acrD, and this response is different to the response
elicited by the inactivation of acrB. This work highlights a previ-
ously underappreciated role of AcrD in the fundamental biology
of Salmonella.
MATERIALS AND METHODS
Bacterial strains and culturemedia.All strains were derived from Salmo-
nella enterica serovar Typhimurium SL1344 (69), and the efflux pump-
inactivated mutant (SL1344 acrD::aph) has been previously described (8,
9). LB broth (Sigma-Aldrich, United Kingdom), M9 minimal medium
(components from Sigma-Aldrich, United Kingdom), and morpholin-
opropanesulfonic acid (MOPS) minimal medium supplemented with
0.2% glucose (Teknova, USA) were used throughout this study.
Microarrays. Microarray experiments were carried out and results
were analyzed exactly as described previously for other strains; they were
carried out in parallel to those with an SL1344 acrB::aphmutant (25, 70).
Briefly, overnight cultures of S. Typhimurium SL1344 and the mutant
strainwere grown inMOPSminimalmedium (glucose) at 37°Cuntil early
logarithmic phase (OD600, ~0.7). For each strain, three biological and two
technical replicate RNApreparationsweremade.Datawere analyzedwith
the Bioconductor (71) and Pathway Tools (72) programs. Data with a B
(log odds value) value of 0, which corresponds to an adjusted P value
of 0.004, were considered significant. The microarray data set is avail-
able at http://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-2975/
samples/ (submitted 10 November 2010, released 1 June 2011, last updated
2 May 2014; minimal medium used [http://www.ebi.ac.uk/arrayexpress/
protocols/87504/?refE-MEXP-2975]).
Phenotypic microarrays. Salmonella Typhimurium strains were cul-
tured from frozen (80°C) stocks on LB agar for 24 h at 37°C, aerobically.
Bacteria were harvested from agar plates and resuspended into IF-0a in-
oculating fluid (Biolog, Inc., USA) and adjusted to 42% transmittance
(turbidimeter; Biolog). A working cell suspension of 10 ml IF-0a, 2 ml of
bacterial suspension, and 120l of tetrazoliumdye (90l dyeD, 30l dye
F; Biolog)wasmade for the PM1 andPM2A carbon utilization plates. One
hundredmicroliters of suspensionwas added to each of the 96wells on the
appropriate PM plates. The inoculated PM plates were placed in an Om-
nilog automatic plate reader (Biolog) and incubated at 37°C, aerobically,
for 48 h. Metabolism of the various carbon sources was recorded every 15
min based on the reduction of the tetrazolium violet redox dye, which
produces a purple color indicative of active bacterial respiration. Abiotic
negative-control plates indicated false-positive results due to autoreduc-
tion of the dye observed in PM1 with L-arabinose, D-xylose, D-ribose, or
L-lyxose. False-positive results observed in PM2A included D-arabinose,
2-deoxy-D-ribose, D-glucosamine, 5-keto-D-gluconic acid, and dihyroxy-
acetone.
Each PM plate preparation was repeated in triplicate for each strain.
The values of the experimental replicates for each strain for each carbon
and nitrogen substrate were compared by a one-way analysis of variance
and Tukey post hoc multiple-comparison test, using a 95% family-wise
confidence level. Statistical significance was assigned at the P 0.05 level.
Bacterial growth in different carbon sources. Bacteria were grown
aerobically at 37°C for approximately 16 h in LB broth and then diluted to
~104 CFU/ml in fresh M9 minimal medium. M9 minimal medium was
used to coincide with that used in previous similar experiments (73).
Growth kinetics were determined inM9minimal medium supplemented
with 6mM L-histidine (Sigma-Aldrich, United Kingdom) (parental strain
SL1344 is a histidine auxotroph) and added carbon source. Carbon
sources tested were glucose (0.4%), fructose (0.4%), succinate (0.2%),
aspartate (0.4%), pyruvate (0.2%), and saccharate (0.05%) (Sigma-
Aldrich, United Kingdom). These concentrations were chosen based on
preliminary experiments which determined the concentrations at which
bacteria were able to grow. For glucose, fructose, and aspartate, absor-
bance was measured at 600 nm in a FLUOstar Optima apparatus (BMG
Labtech, United Kingdom) at 37°C with agitation before each reading,
which was taken every 5 min for 19 h. Data were collected from three
biological and three technical replicates of each strain and are presented as
the average optical density over time. For succinate, pyruvate, and saccha-
rate, growth in the FLUOstar was poor, and therefore growth kinetics
were determined by inoculating 10 ml M9 minimal medium with histi-
dine and the specified carbon source. Cultures were incubated at 37°C
with agitation, and absorbance at 600 nm (OD600) was measured initially
and at 2, 4, 6, 8, 10, 12, and 24 h. Final density (24 h) and generation time
during exponential phase were calculated and analyzed using a two-tailed
Student’s t test. P values of0.05 were considered significant.
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Anaerobic growth. Cultures were set up in an anaerobic chamber
(anaerobic gas growth mixture of 10% CO2, 10% H2, 80% N2) in MOPS
minimal medium supplemented with glucose and 6 mM L-histidine and
incubated at 37°C for 24 h. Growth curves in MOPS minimal medium
with histidine were started with 4% inoculum from overnight cultures
grown anaerobically, and the initial OD600 was measured. The OD600 was
measured every 2 h for the first 10 h and again at 24 h. Three independent
experiments with three biological replicates were completed. Data are
presented as the mean generation time the standard deviation. P values
of0.05 from a two-tailed Student’s t test were considered significant.
Motility assays. Bacterial strains were grown overnight at 37°C in LB
broth with or without antibiotic, as appropriate. LB broth was used be-
cause nutrient-rich broth is required for Salmonella swarming. To prepare
inocula, cells were adjusted to an OD600 of 0.5 in phosphate-buffered
saline (PBS). Motility plates were prepared (the night before inoculation
to allow time to set) by combining LB broth and Difco Bacto agar (BD);
for swimming assays, an agar concentration of 0.3% was used, and for
swarming assays an agar concentration of 0.6%was usedwith the addition
of 5 g/liter glucose. To inoculate swimming plates, a straight loop was
immersed in the inoculum and then stabbed into the center of the swim-
ming plate. These plates were then incubated for 7 h at 37°C. For swarm-
ing assays, 5-l aliquots of inoculumwere spotted on the top of swarming
plates, which were incubated for 16 h at 37°C. Images were taken using a
Syngene Transilluminator box, and ImageJ software was used to quantify
the area covered. Data were analyzed using a two-tailed Student’s t test,
and P values of0.05 were considered significant.
Infection of tissue culture cells.Caco-2 epithelial cells were grown in
Dulbecco’s minimal essential medium (DMEM; Sigma-Aldrich, United
Kingdom) containing 1% (vol/vol) nonessential amino acids (Sigma-
Aldrich, United Kingdom), 1% (vol/vol) L-glutamine (Sigma-Aldrich,
United Kingdom), and 10% fetal bovine serum (FBS; Sigma-Aldrich,
United Kingdom). Cells were polarized by seeding at 1.8  105 cells per
well and grown for 2 weeks, with fresh DMEM added every 2 to 3 days.
Infection assays were carried out as described previously (52). Briefly,
overnight cultures of SL1344 wild-type and the acrD::aph mutant were
grown at 37°C in LB broth, washed in PBS, and then 1 107 bacteria/ml
was added to inoculation medium (DMEM without FBS). Caco-2 cells
were washed 3 times with warm Hanks’ balanced salt solution (HBSS;
Sigma-Aldrich, United Kingdom), and then 1 ml of inoculation medium
was added to each well. At 2 h postinfection, all cells were washed with
HBSS and for the 2-h time point cells, were lysed using 1% Triton X-100
(Sigma-Aldrich, United Kingdom), serially diluted, and plated on LB agar
for bacterial enumeration. For later time points, after washing the inocu-
lation medium containing 100 g/ml of gentamicin was added to each
well and incubated for another 2 h. For the 4-h time point, cells were lysed,
serially diluted, and enumerated as described before. For the 8- and 24-h
time points, medium was replaced with inoculation medium containing
10g/ml gentamicin and cultures were incubated for the remaining time.
Cells were lysed, diluted, and enumerated as described above.
Competitive infections were carried out alongside isolated infections
(described above), with the following changes. Inoculumwas prepared by
combining 5  106 bacteria/ml of wild-type SL1344 and 5  106 bacte-
ria/ml of themutant acrD::aph strain. Inocula and samples from each time
point were serially diluted and plated on LB agar and incubated for 14 to
16 h at 30°C to ensure small colonies. Total colonies were enumerated.
Using velvet squares, colonies were replica plated onto LB agar contain-
ing 50 g/ml kanamycin and then incubated for 16 h, aerobically.
Kanamycin-resistant colonies were enumerated.
Data are presented as the mean CFU of three independent experi-
ments with four replicates each, standard deviations and were analyzed
using a two-tailed Student’s t test. P values of 0.05 were considered
significant.
Competition assays. Bacterial strains were grown statically at 37°C
overnight in LB broth with or without antibiotic, as appropriate. Cells
were washed in PBS, and the cultures were adjusted until the OD600 was
0.3. Wild-type SL1344 (100 l) and mutant acrD::aph cells were added to
10 ml of LB broth (no antibiotics) and incubated at 37°C with aeration.
Fresh broth was inoculated every 24 h. CFU were determined by serial
dilution and plating on LB agar plates at 0 h (inoculum) and 2, 4, 6, 8, 10,
12, 24, 48, and 72 h. Replica platingwith velvet squares onto LB agar plates
containing 50 g/ml of kanamycin was performed to determine the ratio
of wild-type to mutant cells, and competition indices were determined.
Three independent experiments were completed, with three biological
replicates each. Data are presented as mean CFU  standard deviations
and analyzed using a two-tailed Student’s t test. P values of 0.05 were
considered significant.
SPI-1 reporter assays. The chromosomal gfp reporter fused to the
promoter of prgH has been previously described (31), and we have previ-
ously used gfp with the prgH promoter to measure activity of SPI-1 in
individual cells (34). In brief, strains SL1344 prgH=-gfp and SL1344 acrB::
aph prgH=-gfp were grown to mid-logarithmic phase in MOPS minimal
medium. The cells were harvested by centrifugation at 2,200 g at room
temperature, washed, and resuspended in PBS. Bacteria were analyzed by
flow cytometry using a FACSAria2 system (BD Biosciences). Cells were
illuminated with a 488-nm laser, and scatter and GFP fluorescence data
were collected through a 502 LP mirror and 530/30 bandpass filter. For
each sample, 10,000 events were collected.
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